Try our beta test site

Aphtostomatitis and Mucositis Treatment by Natural Herbal Formula (Sorend®)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2011 by Hillel Yaffe Medical Center.
Recruitment status was:  Not yet recruiting
R&T Health Products Ltd.
Information provided by:
Hillel Yaffe Medical Center Identifier:
First received: March 22, 2011
Last updated: NA
Last verified: March 2011
History: No changes posted
Sorend is a water-based formula, which contains carob, melissa and sage. Elder inhabitants of Israel are known to use carob extract to ease sores in the mouth, due to the tannins which create a complex with various proteins and polysaccharides, thus creating an impenetrable layer covering the sores, allowing spontaneous healing.


Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Aphtostomatitis and Mucositis Treatment by Natural Herbal Formula (Sorend®)

Further study details as provided by Hillel Yaffe Medical Center:

Estimated Enrollment: 120
Study Start Date: April 2011
Group no. 1 shall receive Sorend following diagnosis of aphtostomatitis or mucositis.
Sorend placebo
Group no. 2 shall receive Sorend placebo following diagnosis of aphtostomatitis or mucositis.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Community population care

Inclusion Criteria:

  • Herpetic aphtomatitis
  • Bacterial aphtostomatitis
  • Viral aphtostomatitis
  • Fungal aphtostomatitis

Exclusion Criteria:

  • Oncology patients
  • Systematic diseases (Colitis, Crohn, diabetes, Behcet)
  • Pregnancy
  • Arthritis
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01321307

Hillel Yaffe MC, Otolaryngology - Head & Neck Surgery Unit
Hadera, Israel, 38100
Sponsors and Collaborators
Hillel Yaffe Medical Center
R&T Health Products Ltd.
Principal Investigator: Galit Avior, MD Hillel Yaffe Medical Center, Hadera, Israel
  More Information

Responsible Party: Galit Avior, MD, Hillel Yaffe Medical Center Identifier: NCT01321307     History of Changes
Other Study ID Numbers: 91-2010-HYMC 
Study First Received: March 22, 2011
Last Updated: March 22, 2011

Keywords provided by Hillel Yaffe Medical Center:
Mouth sores

Additional relevant MeSH terms:
Gastrointestinal Diseases
Digestive System Diseases
Mouth Diseases
Stomatognathic Diseases processed this record on February 20, 2017